Over 37 million worldwide and 5 million in the US alone have atrial fibrillation (AF), the most common cardiac arrhythmia. AF is linked to a higher stroke risk due to blood clot formation in the left atrial appendage (LAA), a structure responsible for over 90% of embolic strokes in AF patients without valvular issues. For those unable to manage stroke risk with blood thinners or seeking alternatives due to bleeding risks, LAA ligation offers a crucial intervention. This procedure, involving clipping or cinching the LAA, reduces stroke risk and eliminates the need for blood thinners. We have designed and created a prototype that can potentially offer a higher effectiveness and/or lower surgical risks compared to current approaches. More work is needed to verify and validate our design before our first animal tests.